Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan

por Uno, Shuji, Midorikawa, Shuichi, Inoue, Kei, Ichikawa, Daisuke, Ito, Tomoki, Kuroda, Junya, Suzuki, Kenshi
Publicado 2023

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

por Matsue, Kosei, Iwasaki, Hiromi, Chou, Takaaki, Tobinai, Kensei, Sunami, Kazutaka, Ogawa, Yoshiaki, Kurihara, Mari, Midorikawa, Shuichi, Zaki, Mohamed, Doerr, Thomas, Iida, Shinsuke
Publicado 2015

Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study

por Suzuki, Kenshi, Shinagawa, Atsushi, Uchida, Toshiki, Taniwaki, Masafumi, Hirata, Hirokazu, Ishizawa, Kenichi, Matsue, Kosei, Ogawa, Yoshiaki, Shimizu, Takayuki, Otsuka, Maki, Matsumoto, Morio, Iida, Shinsuke, Terui, Yasuhito, Matsumura, Itaru, Ikeda, Takashi, Takezako, Naoki, Ogaki, Yumi, Midorikawa, Shuichi, Houck, Vanessa, Ervin‐Haynes, Annette, Chou, Takaaki
Publicado 2016